Drawing for DIAGNOSTIC DEDUCTIVE PATHWAY

USPTO serial 79287831

DIAGNOSTIC DEDUCTIVE PATHWAY

Reviewed by CopyMark Law Group

Reg. 6350707Status 700Renewal
Filing date
Status date
Registration date
May 18, 2021
Examiner
KEELEY, ALISON REBECCA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DIAGNOSTIC DEDUCTIVE PATHWAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARGARET M. POWERS

MARGARET M. POWERS SHAY GLENN LLP2929 CAMPUS DRIVE, STE 225SAN MATEO, CA 94403UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic testing materials in the nature of reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; reagents for use in diagnostic tests for medical purposesACTIVE—
042Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools for use in research and development of pharmaceutical preparations; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 18, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 4, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 9, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 8, 2021FIMPFINAL DISPOSITION PROCESSED—
Aug 18, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 18, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jan 27, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 27, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 27, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 12, 2020RFNTREFUSAL PROCESSED BY IB—
Aug 21, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 21, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 27, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 27, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 27, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 27, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 27, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 15, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 14, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 5, 2020DOCKASSIGNED TO EXAMINER—
Jun 23, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 19, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 18, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance